Skip to content

PSYCHEMEDICS CORP

Delisted

CIK 806517fmd_09Y1AA2TK2DG83E1FGB8N1SE00Services · Services-Medical LaboratoriesTemplate: Standard

Coverage: Jan 01, 2009 to Dec 31, 2024, 60 periods

Latest annual · FY2024

Millions
Total revenues
20
Gross profit
7
Operating income
(2)
Net income
(2)
Free cash flow
1

Latest quarter · Q4 FY2024

Millions
Total revenues
4
Gross profit
1
Operating income
0
Net income
0
Free cash flow
1
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2021 to FY2024
-7.5%
Revenue, 5 yearsFY2019 to FY2024
-12.2%
Net income, 5 yearsFY2019 to FY2024
n/m

PSYCHEMEDICS CORP financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2024FY2023ChangeSource
Revenue$19.7 million$22.1 million-10.9%10-K 2025-03-24 · proof
Gross profit$7.1 million$8.4 million-15.6%10-K 2025-03-24 · proof
Operating income-$1.9 million-$2.9 million10-K 2025-03-24 · proof
Net income-$1.9 million-$4.2 million10-K 2025-03-24 · proof
Cash from operating activities$929,000-$1.5 million10-K 2025-03-24 · proof
Free cash flow$878,000-$1.6 million10-K 2025-03-24 · proof
Total assets$8.3 million$12.3 million-32.5%10-K 2025-03-24 · proof
Total liabilities$3.2 million$5.7 million-43.6%10-K 2025-03-24 · proof
Cash and cash equivalents$1.4 million$2 million-27.9%10-K 2025-03-24 · proof
What was PSYCHEMEDICS CORP's revenue in fiscal 2024?
PSYCHEMEDICS CORP reported revenue of $19.7 million for fiscal 2024 (the year ended Dec 31, 2024), against $22.1 million the year before (-10.9%). Source: the 10-K filed with the SEC on Mar 24, 2025. SEC
What was PSYCHEMEDICS CORP's gross profit in fiscal 2024?
PSYCHEMEDICS CORP reported gross profit of $7.1 million for fiscal 2024 (the year ended Dec 31, 2024), against $8.4 million the year before (-15.6%). Source: the 10-K filed with the SEC on Mar 24, 2025. SEC
What was PSYCHEMEDICS CORP's operating income in fiscal 2024?
PSYCHEMEDICS CORP reported operating income of -$1.9 million for fiscal 2024 (the year ended Dec 31, 2024), against -$2.9 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2025. SEC
What was PSYCHEMEDICS CORP's net income in fiscal 2024?
PSYCHEMEDICS CORP reported net income of -$1.9 million for fiscal 2024 (the year ended Dec 31, 2024), against -$4.2 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2025. SEC
What was PSYCHEMEDICS CORP's cash from operating activities in fiscal 2024?
PSYCHEMEDICS CORP reported cash from operating activities of $929,000 for fiscal 2024 (the year ended Dec 31, 2024), against -$1.5 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2025. SEC
What was PSYCHEMEDICS CORP's free cash flow in fiscal 2024?
PSYCHEMEDICS CORP reported free cash flow of $878,000 for fiscal 2024 (the year ended Dec 31, 2024), against -$1.6 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2025. SEC
What are PSYCHEMEDICS CORP's total assets?
As of Dec 31, 2024, PSYCHEMEDICS CORP reported total assets of $8.3 million, against $12.3 million a year earlier (-32.5%). Source: the 10-K filed with the SEC on Mar 24, 2025. SEC
What are PSYCHEMEDICS CORP's total liabilities?
As of Dec 31, 2024, PSYCHEMEDICS CORP reported total liabilities of $3.2 million, against $5.7 million a year earlier (-43.6%). Source: the 10-K filed with the SEC on Mar 24, 2025. SEC
What are PSYCHEMEDICS CORP's cash and cash equivalents?
As of Dec 31, 2024, PSYCHEMEDICS CORP reported cash and cash equivalents of $1.4 million, against $2 million a year earlier (-27.9%). Source: the 10-K filed with the SEC on Mar 24, 2025. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:806517&period_type=annual&limit=5"

Information only, not investment advice.